Schedule 13G ownership disclosure

KINIKSA PHARMACEUTICALS LTD

Security class unavailable · CUSIP: G5269C101

Event date: 2020-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,139,817
Percent of class
10.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-20-001669
Form type
SC 13G
Filer
Consonance Capital Management LP
CIK
CIK 1544773
Filed
Jun 16, 2020
Reporting period
Mar 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub